Compass Therapeutics (CMPX) Capital Expenditures (2019 - 2026)
Compass Therapeutics (CMPX) posted Capital Expenditures of $82000.0 for Q1 2026, up 1071.43% sequentially from $7000.0 in Q3 2025, and up 355.56% YoY from $18000.0 in Q1 2025.
Compass Therapeutics (CMPX) Capital Expenditures (2019 - 2026) Analysis & Trends
Compass Therapeutics has reported Capital Expenditures for 8 years, with the latest figure at $82000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 355.56% year-over-year to $82000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89000.0 (up 43.55% YoY) and the FY2025 annual result came in at $25000.0, down 43.18% from the prior year.
- Capital Expenditures rose to $82000.0 in Q1 2026 per CMPX's latest filing, from $7000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $194000.0 in Q1 2022 and troughed at -$117000.0 in Q2 2022.
- A 5-year average of $35727.3 and a median of $18000.0 in 2025 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2026: Capital Expenditures tumbled 89.76% in 2022, then soared 355.56% in 2026.
- Over 5 years, Capital Expenditures stood at $54000.0 in 2022, then plunged by 83.33% to $9000.0 in 2023, then surged by 388.89% to $44000.0 in 2024, then tumbled by 84.09% to $7000.0 in 2025, then jumped by 1071.43% to $82000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $82000.0, $7000.0, and $18000.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 176,000.00 |
| Jun 30, 2026 | 176,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 81,000.00 |
| Sep 30, 2022 | 81,000.00 |